Condition: Ischemic Stroke · Sponsor: Kafrelsheikh University
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
This description comes directly from the study's public registry record.
mohamed G. Zeinhom, MD · 2001009606828 · mohamed_gomaa@med.kfs.edu.eg
sherihan R. ahmed, MD · 2001113432342 · sherihan_rezq@med.kfs.edu.eg
Always discuss trial participation with your own doctor first.
| Kafr Elsheikh University Hospital | Kafr ash Shaykh, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06591390